Shares of biopharmaceutical company Praxis Precision Medicines Inc. are soaring, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback